A new study presented at a major gastroenterology meeting sheds light on who develops cirrhosis from metabolic dysfunction-associated steatotic liver disease (MASLD) at a younger age. Researchers found that one in four patients with MASLD-related cirrhosis presented before their 50th birthday, a group with distinct clinical characteristics.
The study highlighted that these young-onset patients more frequently had inherited genetic risk factors and type 2 diabetes compared to those who developed cirrhosis later in life. The findings suggest that younger patients with MASLD may follow a different disease trajectory, and that genetic predisposition combined with metabolic comorbidities could accelerate progression to cirrhosis.
The authors emphasize the need for heightened awareness and earlier screening in younger adults with MASLD, particularly those with diabetes or a family history of liver disease. Further research is needed to confirm these associations and to develop targeted prevention strategies for this higher-risk subgroup.